Publication | Open Access
Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial
13
Citations
17
References
2023
Year
Pimavanserin significantly reduced risk of psychosis relapse in patients with PDD, was well tolerated, and did not worsen motor or cognitive function.
| Year | Citations | |
|---|---|---|
Page 1
Page 1